I have read and accept the Privacy Policy.

*Required Fields

CPhI Pharma Insights reports: CPhI, the world’s leading pharmaceutical networking event, with over 100,000 attendees globally – is now using its collective resources to create Pharma Insight reports, analysing individual parts of the pharma industry as well creating the well respected and eagerly anticipated Annual Report featuring a global panel of experts (now in its second year). The vision is to harness the power of CPhI’s independent position within the industry so that it can produce unbiased analysis of the global pharmaceutical industry and help to see emerging trends and bring different perspectives together. The Annual Report utilises expert in-depth essays, looking at future contingencies, whilst the Pharma Insights series takes perspectives from CPhI exhibitors and the wider industry.

Copyright © 2016 UBM

This CPhI report announces the findings from a comprehensive review of the Unites States of America pharmaceutical manufacturing. The US pharma industry and domestic manufacturers are showing increased confidence of renewed growth and even the returning of some lower cost manufacturing work that has, in previous years, been outsourced overseas. This turnaround in the US market’s revenue potential is being driven by concerns of quality in some Asian markets and a marked shift in the drug development pipeline towards difficult to formulate drugs and biosimilars.
Fix the following errors: